Proinflammatory CD20<sup>+</sup> T Cells are Differentially Affected by Multiple Sclerosis Therapeutics.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Works by Häusser‐Kinzel, Silke
Results: 6
1
2
Dimethyl fumarate impairs differentiated B cells and fosters central nervous system integrity in treatment of multiple sclerosis.
- Published in:
- Brain Pathology, 2019, v. 29, n. 5, p. 640, doi. 10.1111/bpa.12711
- By:
- Publication type:
- Article
3
Differential Effects of MS Therapeutics on B Cells—Implications for Their Use and Failure in AQP4-Positive NMOSD Patients.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 14, p. 5021, doi. 10.3390/ijms21145021
- By:
- Publication type:
- Article
4
IL-10-providing B cells govern pro-inflammatory activity of macrophages and microglia in CNS autoimmunity.
- Published in:
- Acta Neuropathologica, 2023, v. 145, n. 4, p. 461, doi. 10.1007/s00401-023-02552-6
- By:
- Publication type:
- Article
5
Proinflammatory CD20<sup>+</sup> T cells contribute to CNS-directed autoimmunity.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 638, p. 1, doi. 10.1126/scitranslmed.abi4632
- By:
- Publication type:
- Article
6
Natalizumab promotes activation and pro-inflammatory differentiation of peripheral B cells in multiple sclerosis patients.
- Published in:
- 2019
- By:
- Publication type:
- journal article